《盈警》神華(01088.HK)料中期純利跌最多18.4%至256億人幣 初段股價照升近4%
中國神華(01088.HK)上日(13日)公布,預計集團2025年上半年歸屬於公司所有者利潤為256億元至276億元人民幣(下同)。與上年同期披露數據相比下降15.8%至21.9%。與經重述的上年同期數據相比,下降12%至18.4%。
公司指,利潤按年下降的主要原因,是受煤炭銷售量及平均銷售價格下降影響,集團煤炭分部利潤下降。
中國神華今早(14日)高開0.3%後,初段升幅擴大,最高見32.35元。現報32.2元,升3.87%,成交712.55萬股,涉資2.28億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.